619
Views
4
CrossRef citations to date
0
Altmetric
Clinical Studies

Peritoneal cells at admission: do they have prognostic significance in peritonitis?

, , &
Pages 335-342 | Received 01 Oct 2009, Accepted 16 Dec 2009, Published online: 06 Apr 2010

REFERENCES

  • Kent JR, Almond MK. A survey of CAPD peritonitis management and outcomes in North and South Thames NHS regions (U.K.): Support for the ISPD guidelines. International Society for Peritoneal Dialysis. Perit Dial Int. 2000;20:301–305.
  • Hurst SM, Wilkinson TS, McLoughlin RM, IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity. 2001;14:705–714.
  • Enriquez J, Klinger J, Arturo JA, Delgado M, Tobar C, Mosquera M. Peritonitis in continuous ambulatory peritoneal dialysis: Cytokines in peritoneal fluid and blood. Adv Perit Dial. 2002;18:177–183.
  • Shetty H, Gokal R. Treatment of infections in peritoneal dialysis. Contrib Nephrol. 2003;140:187–194.
  • Diaz-Buxo JA. What is the role of automated peritoneal dialysis and continuous flow peritoneal dialysis? Contrib Nephrol. 2003;140:264–271.
  • McLoughlin R. Resolving peritoneal inflammation: Flicking the right “switches”. Perit Dial Int. 2005;25:223–229.
  • Henderson RB, Hobbs JA, Mathies M, Hogg N. Rapid recruitment of inflammatory monocytes is independent of neutrophil migration. Blood. 2003;102:328–335.
  • Tzamaloukas AH. What affects the outcome of peritoneal dialysis? Going beyond the microbial etiology. Perit Dial Int. 2002;22:563–565.
  • Glik A, Douvdevani A. T lymphocytes: The “cellular” arm of acquired immunity in the peritoneum. Perit Dial Int. 2006;26:438–448.
  • Continuous ambulatory peritoneal dialysis (CAPD) peritonitis treatment recommendations: 1989 update. The Ad Hoc Advisory Committee on Peritonitis Management. Perit Dial Int. 1989;9:247–256.
  • Troidle L, Finkelstein F. Treatment and outcome of CPD-associated peritonitis. Ann Clin Microbiol Antimicrob. 2006;5:6.
  • Piraino B, Bailie GR, Bernardini J, ISPD Ad Hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005;25:107–131.
  • Glik A, Mazar J, Rogachev B, Zlotnik M, Douvdevani A. CD40 ligand expression correlates with resolution of peritonitis and mononuclear cell recruitment. Perit Dial Int. 2005;25:240–247.
  • Zelenitsky S, Barns L, Findlay I, Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis. 2000;36:1009–1013.
  • Korbet SM, Vonesh EF, Firanek CA. Peritonitis in an urban peritoneal dialysis program: An analysis of infecting pathogens. Am J Kidney Dis. 1995;26:47–53.
  • Bernardini J, Holley JL, Johnston JR, Perlmutter JA, Piraino B. An analysis of ten-year trends in infections in adults on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol. 1991;36:29–34.
  • Krishnan M, Thodis E, Ikonomopoulos D, Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int. 2002;22:573–581.
  • Kim GC, Korbet SM. Polymicrobial peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis. 2000;36:1000–1008.
  • Bunke M, Brier ME, Golper TA. Culture-negative CAPD peritonitis: The Network 9 Study. Adv Perit Dial. 1994;10:174–178.
  • Troidle L, Majahan A, Gorban-Breannan N, Kliger AS, Finkelstein FO. C-reactive protein, peritonitis and outcome. Perit Dial Int. 2001;21(Suppl. 1):S45.
  • Troidle L, Gorban-Brennan N, Kliger A, Finkelstein FO. Continuous peritoneal dialysis-associated peritonitis: A review and current concepts. Semin Dial. 2003;16:428–437.
  • Perez Fontan M, Rodriguez-Carmona A, Garcia-Naveiro R, Rosales M, Villaverde P, Valdes F. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int. 2005;25:274–284.
  • Cueto-Manzano AM, Quintana-Pina E, Correa-Rotter R. Long-term CAPD survival and analysis of mortality risk factors: 12-year experience of a single Mexican center. Perit Dial Int. 2001;21:148–153.
  • Szeto CC. Peritonitis-cells, cytokines, and local defense. Hong Kong J Nephrol. 2002;4:63–64.
  • Martikainen TA, Ekstrand AV, Honkanen EO, Teppo AM, Gronhagen-Riska C. Dialysate leukocytes, sICAM-1, hyaluronan and IL-6: Predictors of outcome of peritonitis? Blood Purif. 2004;22:360–366.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.